Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG2WR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,697
Award facts
- Contract value 100% obligated
- $23,697.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,697.40 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated SPE2DX and extending through December 2026. Gamunex-C is an intravenous immunoglobulin (IVIG) therapy used to treat various immunodeficiency and autoimmune conditions, critical for military healthcare support worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a primary vendor for federal medical procurement across the Defense Health System. The company was competitively selected for this delivery order based on its demonstrated capability to supply a comprehensive range of pharmaceutical products to support military healthcare programs. As the prime contractor on this award, AmerisourceBergen will perform work at its corporate office location in Conshohocken, PA, supplying the specialized immunoglobulin therapy to support Defense Department medical needs.
Quick answers
Who was awarded contract SPE2DR26FG2WR?
SPE2DR26FG2WR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FG2WR worth?
The government has obligated $23,697 on SPE2DR26FG2WR.
Is contract SPE2DR26FG2WR an order under another contract?
Yes. SPE2DR26FG2WR is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2WR competed?
The extent of competition for SPE2DR26FG2WR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award